Summer Sale
50% off Premium Yearly
NYSE:GMED
Globus Medical (GMED)
Financials 
Technical Analysis 
Jun 19, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Globus Medical, symbol GMED-N, operates in a challenging environment for medical device companies, as the market sentiment currently leans negatively towards this sector. Experts indicate that there is a general aversion to investments in medical devices, particularly larger companies like Medtronic, which have not shown significant returns lately. This suggests that even promising companies in the space, including Globus Medical, may struggle to attract investor interest amidst these broader market concerns. Despite the potential for growth in orthopedic medical devices, the lack of immediate financial gains from more established players raises questions about the near-term performance of newer entrants like GMED. Consequently, investors may need to proceed with caution and closely monitor market trends to reassess the viability of their investments in this sector.
He recommended it around 18 months ago, and it has doubled in price. Drawbacks before: had no international presence and not enough salespeople, but that has turned around, as reflected in the price jump. Earnings growing 10-15% annually. No debt, but pay no dividend. Buy half a position and watch, but don't buy heavily because it may
drop badly during a correction.
Since he recommended this, it’s gone from $22 to $46. This is medical technology for spying related injuries. The stock price has taken off because the company has gotten their act together and has started to move outside of the US. Their sales teams are in place. A lot of their competitors have not been allocating capital towards the spine business. This company just came out with a new robotic invention that will help surgeons do all the spine surgeries. Earnings have jumped up nicely, and he is expecting anywhere from $143-$178 a share over the next couple of years, but we are still seeing the stock trading at roughly 32X earnings. Wait for a pullback or just buy half for the moment.
David DriscollThis is a tiny little $2 billion company that is in robotics of spinal care. Growing at a wonderful rate, but the street hasn’t adapted to them.
David Driscoll- «
- ‹
- 1
- ›
- »
Globus Medical (GMED) Frequently Asked Questions
What is Globus Medical stock symbol?
Globus Medical is a American stock, trading under the symbol GMED (previously GMED-N on Stockchase) on the New York Stock Exchange (GMED). It is usually referred to as NYSE:GMED or GMED
Is Globus Medical a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on GMED (previously GMED-N on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Globus Medical.
Is Globus Medical a good investment or a top pick?
Globus Medical was recommended as a Top Pick by David Driscoll on 2016-06-07. Read the latest stock experts ratings for Globus Medical.
Why is Globus Medical stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Globus Medical.
Is Globus Medical worth watching?
Globus Medical is followed by 10 investors on Stockchase and is a trending stock that is worth watching.
What is Globus Medical stock price?
On 2026-06-18, Globus Medical (GMED) stock closed at a price of $79.21.
The market hates medical devices now and there's little money made in bigger players like Medtronic.